Background. In sub-Saharan Africa, the number of persons living with human immunodeficiency virus (HIV) has increased immensely. In parallel, rates of noncommunicable diseases, especially cardiovascular disease, are rising rapidly in resource-limited settings. This study aims to evaluate the relation between subclinical atherosclerosis and HIV-related and traditional cardiovascular risk factors in HIV-infected patients in rural South Africa.
In the last decade, the massive rollout of antiretroviral therapy (ART) in sub-Saharan Africa (SSA) has positively resulted in improved life expectancy for persons living with human immunodeficiency virus (HIV).
HIV infection has thus become a chronic disease, with an increasing number of patients receiving lifelong treatment. Hence, the large number of HIV-infected subjects in SSA is still growing [1] . In parallel, the prevalence of noncommunicable diseases in resourcelimited settings is high and rising rapidly in the last decade [2] . Currently, >75% of the 17.5 million persons worldwide who die annually of cardiovascular disease (CVD) and diabetes mellitus (DM) live in resourcelimited settings [3] .
HIV-infected persons in SSA are expected to be at particular risk for developing CVD. As life expectancy rises, the chances of experiencing a cardiovascular event increase [4] . Moreover, the "traditional" cardiovascular risk factors are at least equally prevalent among HIV-infected persons as in the total population [5] [6] [7] [8] [9] [10] . Finally, HIV infection and its treatment have been shown to be additional risk factors themselves, although studies on this subject have mainly been performed in Western countries [11] . The chronic systemic inflammation seen in HIV-infected patients may interfere with endothelial function and therefore influence the risk of vascular disease. Moreover, the use of ART is associated with several metabolic risk factors, including insulin resistance and dyslipidemia, which again can predispose persons to CVD [12, 13] .
However, the effects of HIV and its treatment on cardiovascular morbidity and mortality in SSA may be different for various reasons. HIV subtypes circulating in SSA differ from those in Western countries; subtype C is most frequent in African countries, and subtype B most frequent in Western countries [14] . The effects of different viral subtypes on the cardiovascular system remain unclear. Furthermore, the population in SSA differs from the extensively studied Western population, in its sociodemographic profile, the prevalence of traditional risk factors, and its genetic makeup.
HIV-infected patients in SSA are generally not routinely screened for cardiovascular risk factors and diseases, and limited data are available. As in Western populations, HIV infection and ART are suggested to be associated with cardiometabolic traits [15] . However, existing studies have been limited by cohort size, by being retrospective, or by focusing solely on risk factors, without determining the prevalence of cardiovascular end points or disease. In the current cross-sectional study, we evaluated the relation between subclinical atherosclerosis, as measured with carotid intima media thickness (CIMT), and HIV-related and traditional cardiovascular risk factors in HIV-infected patients in a primary care setting in rural South Africa.
METHODS

Setting/Study Site
Elandsdoorn is a township situated in a poor, rural area in Limpopo, a province in the northeast of the Republic of South Africa. Ndlovu Medical Centre is a nongovernmental organization in Elandsdoorn (www.ndlovucaregroup.co.za) that provides primary healthcare, as well as tuberculosis and HIV/AIDS programs. It serves a population of approximately 120 000-140 000 persons, and about 3600 HIV-infected patients are in care at the clinic.
Data Collection
Between May and December 2013, HIV-infected patients aged ≥18 years were randomly selected and requested to participate in the study, regardless of severity of disease or underlying comorbid conditions. Patients unable to undergo the study procedures for any reason were excluded. Routine clinical care was not interrupted for the current study.
All participants completed a baseline questionnaire to obtain demographic data and information about comedication, other cardiovascular risk factors, and previous diseases. Additional medical information was obtained from the clinical files, including known duration of HIV infection, start date of ART, current ART regimen, and previous changes in regimen. The latest CD4 cell count and HIV load were registered if the measurements were <18 months old, taking into account the routinely follow-up duration of 12 months for stable patients, plus an extra margin of 6 months. The viral load was depicted as <50 copies/mL if undetectable and assumed to be detectable if missing in ART-naive patients, for further analyses.
Height, weight, waist circumference, and blood pressure were measured according to standard procedures. Body mass index (BMI) was calculated. Obesity and overweight were defined as a BMI ≥30 and ≥25 kg/m 2 , respectively. Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or the use of antihypertensive medication.
Plasma and urine samples were analyzed in the laboratory (Toga laboratories, accredited by the South African National Accreditation System). Laboratory investigations included serum creatinine, glycated hemoglobin, serum alanine transaminase, and lipid spectrum (total cholesterol, high-density lipoprotein cholesterol, and triglycerides). Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation [16] . The estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation based on age, sex, race, and serum creatinine level [17] . Urine microalbumin and creatinine levels were measured quantitatively, and the urine albumin-creatinine ratio was calculated; a ratio >30 mg/g was considered moderately increased albuminuria [18] .
Diabetes mellitus (DM) was defined as glycated hemoglobin ≥6.5% or the use of diabetes medication. The presence of metabolic syndrome (MetS), defined according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATPIII) guidelines, was determined for each individual [19] . The Framingham 10-year heart risk score (FHS-10) was calculated for patients without DM or a previous cardiovascular event [20] . The likelihood of having coronary heart disease in the next 10 years (expressed as a percentage) was reported.
Ethical approval for this study was obtained from the 
B-Mode Ultrasound CIMT Measurements
CIMT ultrasound measurements can be used to noninvasively assess early atherosclerotic arterial wall change. CIMT is associated with the risk of stroke and myocardial infarction and is a wellvalidated surrogate imaging end point for cardiovascular status and future cardiovascular morbidity and mortality risk [21] .
In all subjects, right and left common carotid and carotid bulb arterial segments were scanned from a fixed lateral angle by trained and certified sonographers. An Acuson Aspen ultrasound instrument (Siemens) equipped with a linear array broadband transducer (5-12 MHz) and extended frequency software was used. For each arterial segment, a high-resolution 2 × 2 cm DICOM (digital imaging and communications in medicine) still image was saved to a magneto-optical disc. Images were securely transferred to the ultrasound core laboratory (Imagelabonline & Cardiovascular, Eindhoven and Lunteren, the Netherlands). One in 10 subjects permitted a rescan for quality control purposes. Direct feedback to sonographers and quality control was implemented during the study.
Standardized equipment and protocols were used for image and data management. Qualitative and quantitative image analyses were performed with in-house developed software (eTrack, Academic Medical Center, Amsterdam). On each image, analysts selected a region of interest. Cursors were placed along the leading edges of the lumen-intima and media-adventitia interfaces and splined by the software. The mean distance between the splines, defined as the mean intima media thickness (IMT), was calculated for each view.
Data Analysis
Patient characteristics were described by calculating medians with interquartile ranges (IQRs) for continuous variables, and proportions (as percentages) for categorical variables. The primary atherosclerosis end point was the mean CIMT. For every carotid segment, we used the IMT values of the far wall left and right, referred to as mean common CIMT (CCIMT) and mean bulb carotid IMT (bulb CIMT), respectively. Finally, the mean CIMT was determined by using the average of the mean CCIMT and mean bulb CIMT only if both IMT measurements were available for the subject.
Scatterplots were provided to elucidate the relationship between CIMT and age, for each sex separately. Results for mean CCIMT from our study cohort were compared with those for a reference group, derived from a healthy Western population without previous CVD or medication, plotted separately in the graphs [22] . Subclinical atherosclerosis was defined as a mean CIMT >0.78 mm, based on findings from a study in the Netherlands, which led to the estimation that, on average, a healthy person reaches a CIMT of 0.78 mm at age 76 years [23] . The characteristics of patients with subclinical atherosclerosis were determined.
Linear regression analysis was performed by using various models with mean CIMT as the dependent variable for the total group and for female participants only. Analyses were repeated using mean CCIMT and bulb CIMT as the dependent variable separately, to explore IMT in the different segments. Binary logistic regression models were used to analyze which variables were associated with subclinical atherosclerosis.
Univariate analyses were performed for all available determinants, including demographic variables, HIV-related factors, and traditional cardiovascular risk factors. Subsequently, models were adjusted for age and sex. Finally, a multivariable model was used, including all HIV-related determinants as well as demographic characteristics and cardiovascular risk factors. Differences were considered statistically significant at P < .05. Data were processed and statistical analyses were done using SPSS software, version 21.0.
RESULTS
In total, 906 HIV-infected patients were screened, and 904 with available CIMT measurements were included in the study. All participants were of black African ethnicity. Almost 70% were female (626 of 904; 69%), and the median age was 40.7 years (IQR, 34.8-48.0 years). The median known duration of HIV infection was 2.2 years (IQR, 1.0-4.8 years) and >85% of patients were receiving ART, of whom the vast majority (539 of 789; 68%) had reached virological suppression (HIV load, <50 copies/mL). The immune status of the total study group was reasonably well preserved, with a median CD4 cell count of 388/ µL, although still a quarter were immunocompromised, as shown by a CD4 cell count <200/µL.
Hypertension and obesity were diagnosed in approximately one-fifth of participants. Smoking was more prevalent among male subjects (36% vs 14% of women). Five percent of the participants had a diagnosis of DM. The proportions of patients receiving treatment for hypertension or DM were low, 22% (46 of 205) and 41% (17 of 41), respectively. Almost 1 in 6 patients (143 of 904) were shown to have MetS according to the NCEP ATPIII guidelines. Among 832 patients without a previous cardiovascular event or DM, 6% had a FHS-10 >10%. A full list of characteristics of the study population is provided in Table 1 .
The CCIMT values were available for all 904 patients, but 38 subjects had missing bulb CIMT results because of lacking or unreadable images. As a result, mean CIMT values were available for 866 subjects. Patients with missing bulb CIMT had longer known durations of HIV infection, higher CD4 cell counts, and larger BMIs than patients with available results, and more of them were hypertensive. All other determinants were similar between groups.
The median (IQR) value for mean CIMT was 0.589 (0.524-0.678) mm, 0.579 (0.517-0.663) mm for female and 0.609 Figure 1A . They show that the linear CCIMT regression line of HIV subjects is increased compared with IMT data acquired according to the same scan and image analysis protocol in the reference group [22] . Figure 1B shows mean CIMT results in HIV subjects and the cutoff value of an unaffected study group, illustrating that those affected reach a threshold CIMT value of 0.78 mm more than a decade earlier than the reference group. Overall, 12% of subjects (106 of 866) had subclinical atherosclerosis. Characteristics of the subgroups with or without subclinical atherosclerosis are presented in Table 1 .
In univariate linear regression analysis, both older age and male sex were strongly associated with higher mean CIMT. Hypertension was also significantly related, as were BMI, smoking, a previous cardiovascular event, DM, total and LDL cholesterol and triglyceride levels, moderately increased albuminuria, eGFR, MetS, and FHS-10. None of the HIV-related variables were significantly associated with mean CIMT in univariate analysis.
After adjustment for both age and sex, determinants that were significantly related to mean CIMT were hypertension, BMI, a previous cardiovascular event, DM, total and LDL cholesterol levels, eGFR, MetS, and FHS-10. HIV determinants remained unrelated to mean CIMT after adjustments for age and sex. Results of linear regression analyses are shown in Table 2 . In a model including all variables (HIV related as well as demographic and cardiovascular), still no association between HIV infection and CIMT could be demonstrated.
Results of linear regression analyses in the female participants only were comparable to those in the total group, showing similar associations between traditional cardiovascular risk factors and mean CIMT and no association between HIV-related determinants and outcome (results not shown). When analyses were repeated with mean CCIMT or bulb CIMT as a dependent variable, comparable associations were found, although eGFR was not significantly related to increased CCIMT, and a previous cardiovascular event, total and LDL cholesterol levels, and eGFR were not related to increased bulb CIMT (results not shown).
In binary logistic regression, analyses with subclinical atherosclerosis as a dependent variable showed results similar to those of the linear regression models. The following determinants were independently associated with subclinical atherosclerosis, after adjustment for age and sex: hypertension, BMI, previous cardiovascular event, increased total and LDL cholesterol and triglyceride levels, DM, MetS, and FHS-10. Again, no HIVrelated factors were independently associated with subclinical atherosclerosis (see Supplementary data).
DISCUSSION
The findings of this study show that CIMTs in HIV-infected subjects in a rural area in South Africa are considerably elevated and that subclinical atherosclerosis is present in a substantial number of HIV-infected persons. Highly prevalent traditional cardiovascular risk factors are related to increased CIMT, in contrast to HIV-related factors.
To our knowledge, this is the first report to describe CIMTs in a large number of HIV-infected subjects in an SSA setting, with a vast majority of female subjects. One cross-sectional study from Uganda investigated the prevalence of subclinical atherosclerosis in 186 HIV-infected adults and the correlation between such atherosclerosis and traditional risk factors [24] . Using the same CIMT cutoff value as in the current study, that study found that 18% of the population had signs of subclinical atherosclerosis, slightly more than the proportion in our study. The prevalence of cardiovascular risk factors was comparable between study groups, but the Ugandan cohort was smaller, and fewer participants were receiving ART than in our study group. In the current study, traditional cardiovascular risk factors were associated with increased CIMT and seemed to contribute more to the development of atherosclerosis than HIV-related factors. These results are comparable to findings of research performed in Western HIV-infected subjects. The associations between hypertension, BMI, a previous cardiovascular event, total and LDL cholesterol levels, DM, eGFR, and CVD are well known and described in various HIV-infected populations [25] [26] [27] [28] [29] . We could not detect an association between smoking and CIMT in the current study. The association of CIMT with MetS and FHS-10 shows that both risk models are useful tools for assessing CVD risk in this population.
Although it is assumed that HIV infection and its treatment influence cardiovascular risk, we did not find a relation between HIV-specific factors and CIMT. The relatively short median duration of HIV infection (<2 years) may have limited the effect of HIV-related determinants in the current study. CD4 cell count, HIV load, and known duration of infection were not independently associated with subclinical atherosclerosis, in contrast to earlier reports [13, 26, 30] . We did not have information on the nadir CD4 cell counts for the study population. A minority of participants had an increased HIV load, and our study may have lacked power to detect a moderate association with Figure 1 . A, Sex-specific mean common carotid intima media thickness (CCIMT) with reference lines. CCIMT measurements were available for 904 subjects. Reference lines were based on findings from Engelen et al [22] , derived from a healthy Western population without previous cardiovascular disease or cardiovascular medication. Reference values were adjusted for age according to the following equations for female subjects: Mean CCIMT (in mm) = 0.001 × (321.7 + 4.971 × Age [in y]); and male subjects: Mean CCIMT (in mm) = 0.001 × (323.5 + 5.201 × Age [in y]). B, Sex-specific mean carotid intima media thickness (CIMT) with reference lines. Mean CIMT was the average of mean CCIMT and mean bulb carotid intima media thickness. Mean CIMT values were available for 866 subjects. The reference line (0.78 mm) is based on findings from de Groot et al [23] , from an observational study in the Netherlands, which led to the estimation that, on average, a healthy person reaches a CIMT of 0.78 mm by age 76 years. Abbreviation: HIV, human immunodeficiency virus.
CIMT. Moreover, we did not see an effect of treatment with ART or ART regimen on CIMT outcome. An association between protease inhibitor use and enlarged CIMT among HIV-infected persons has been observed elsewhere [26, 31] , but this could not be confirmed in our study. However, the power to detect such a relation within this study population may have been too small, with only a small proportion of patients receiving protease inhibitor-based second-line ART and substantial heterogeneity within this subgroup.
The relatively large CIMT values in this study population, compared with healthy Western study groups, might be explained by both our subjects' positive HIV status and their African ancestry. A larger CIMT among HIV-infected persons has been described, as well as a faster rate of progression of CIMT over time, compared with HIV-negative persons [13, 28, 32] . African ethnicity and the genetic makeup of persons in our cohort could also contribute to the larger CIMT values, because Africans have been shown to have larger CIMTs than non-Africans [33] .
A difficulty in studying CIMT values is the lack of a general cutoff point, because of its variations between different populations. CIMT measurements depend on multiple factors, including the composition of the study population and exact methods of CIMT measurements and analyses [22, 34] . However, it is possible to relate measured CIMT values with those in other specified populations. Gathering information on CIMT values in "new" ( previously undescribed) populations increases our knowledge and the accessibility to reference values. Our cutoff value of 0.78 mm, used to define increased CIMT, was based on findings from a study leading to the estimation that, on average, a healthy person reaches this value at age 76 years [23] . The median age of subjects with subclinical atherosclerosis in our study group was only 52 years. Thus, high CIMT values were observed at a younger age in a subgroup of our South African population.
Our current findings are important for HIV care in resourcelimited settings where noncommunicable diseases are on the rise. They show that traditional cardiovascular risk factors are highly prevalent and play an important role in the development of long-term complications among persons living with HIV. Cardiovascular screening and prevention are currently not part of routine HIV care in this setting, where many persons suffer from financial constraints and cannot afford antihypertensive, lipid-lowering, or diabetes therapy. Screening and treatment of noncommunicable diseases, especially CVD, should be a part of clinical care, which requires a reorganization of financial resources. This is a challenging task, but hopefully it is nevertheless achievable.
The strength of this study is the large number of HIV-infected patients included, leading to a more precise estimation of the distribution of CIMTs and prevalence of subclinical atherosclerosis. It is one of the first studies describing the relation between variables associated with a surrogate cardiovascular end point in an SSA setting, where the majority of the worldwide HIVinfected population lives. The study also has some limitations. A lack of an HIV-negative control group made it impossible to draw any conclusions on the true effect of HIV infection on CIMT. Furthermore, because of the descriptive cross-sectional design, only associations and no causality could be demonstrated. A longitudinal prospective cohort study with CIMT measurement and hard cardiovascular end points could give more information on progression of CIMT and the occurrence of CVD. Still, CIMT is a good surrogate for the incidence of cardiovascular end points, such as stroke and myocardial infarction [21] .
In conclusion, in this HIV-infected population in rural South Africa, CIMT values are relatively high and associated with traditional cardiovascular risk factors rather than HIV-related factors. This emphasizes the need for screening and prevention for CVD among persons living with chronic HIV infection in resource-limited settings, which ideally would be integrated into HIV care in the current healthcare systems. This would require a reorganization of financial resources and is a major challenge for the near future.
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